-
2023-508214-42-00
5
2020-05-25
Previously treated locally advanced and unresectable or metastatic
non
-
2022-501531-16-00
5
2020-01-24
esophageal carcinoma
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2024-510626-89-00
5
2019-11-18
Non-Alcoholic Steatohepatitis (NASH)
-
2024-510776-20-00
5
2019-10-25
Female or male patients with histologically confirmed HR-positive, HER
-
2024-518836-36-00
5
2019-10-07
Respiratory Distress Syndrome of preterm babies born < 32 weeks of ges
-
2024-515946-17-00
5
2019-07-22
Non Small Cell Lung Cancer
-
2024-514885-38-00
5
2019-07-11
severe forms of mucous membrane pemphigoid
-
2024-515352-20-00
4
2019-03-20
myelodysplastic syndrome with IDH1 mutated
-
2022-500451-23-00
5
2019-03-18
Adults with a de novo glioblastoma
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
-
2023-506125-10-00
5
2018-12-24
Multiple Myeloma
-
2024-512470-10-00
11
2018-02-02
End-stage Renal disease
-
2023-506110-43-00
9
2018-01-25
Multiple Myeloma
-
2024-516112-21-00
5
2017-11-20
Newly diagnosed acute myeloid leukaemia (AML), high risk myelodysplast
-
2024-516601-23-00
5
2017-11-14
Colorectal adenomas
-
2024-515846-18-00
7
2016-09-19
Newly diagnosed Diffuse Large B Cell Lymphoma
-
2023-507889-89-00
5
2016-02-19
Respiratory tract infection
-
2024-513079-42-00
5
2015-11-19
Intermediate-risk, high risk endometrial cancer
-
2024-518741-21-00
4
2014-12-23
colon cancer
-
2024-518450-16-00
9
2025-06-13
Cardiogenic shock due to Acute Coronary Syndrome, cardiogenic shock of
-
2024-511244-12-01
5
Amyotrophic Lateral Sclerosis
-
2024-514946-35-00
4
2025-06-24
Sepsis-Induced Hypotension
-
2024-519977-20-00
4
2025-01-27
Acute Anterior Ischemic Optic Neuropathy associated with Giant Cell Ar